TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By Type
1.3.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By PET Product
1.3.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By End User
1.3.4 APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Prostate Cancer Nuclear Medicine Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Prostate Cancer Nuclear Medicine Diagnostics Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Developing Prevalence of Prostate Cancer
5.1.2 Growing Demand for Early and Precise Diagnosis of Prostate Cancer
5.2 Market Restraints
5.2.1 High Price Related to the Prostate Cancer Diagnostics and Treatment
5.3 Market Opportunities
5.3.1 Increasing Use of Radiopharmaceuticals in Prostate Cancer
5.4 Future Trends
5.4.1 Growing Research Activities for Development of Innovative Imaging Agents
5.5 Impact Analysis
6. Prostate Cancer Nuclear Medicine Diagnostics Market– APAC Analysis
6.1 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Forecast and Analysis
7. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By Type
7.1 Overview
7.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2022 & 2028 (%)
7.3 SPECT
7.3.1 Overview
7.3.2 SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 PET
7.4.1 Overview
7.4.2 PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By PET Product
8.1 Overview
8.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2022 & 2028 (%)
8.3 F-18
8.3.1 Overview
8.3.2 F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 C-11
8.4.1 Overview
8.4.2 C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 GA 68 PSMA
8.5.1 Overview
8.5.2 GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By End User
9.1 Overview
9.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User- 2022 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By Country Analysis
10.1 APAC: Prostate Cancer Nuclear Medicine Diagnostics Market
10.1.1 Overview
10.1.2 APAC: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
10.1.2.1 China: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 China: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.1.4 China: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.1.5 China: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.2 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.2.4 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.2.5 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.3 India: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 India: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.3.4 India: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.3.5 India: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.4 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.4.4 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.4.5 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.5 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.5.4 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.5.5 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.6 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
11. Prostate Cancer Nuclear Medicine Diagnostics Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 ImaginAb
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Curium
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Jubilant Radiopharma
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 ABX advanced biochemical compounds GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Telix Pharmaceuticals Ltd.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Novartis AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Lantheus Medical Imaging, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES.
Table 1. China: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 3. China Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 4. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 7. India: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type– Revenue and Forecast to 2028 (US$ Million)
Table 8. India: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 9. India Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 10. Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 12. Australia Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 13. South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 15. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 16. Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 19. Recent Inorganic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market
Table 20. Recent Organic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market
Table 21. Glossary of Terms, Prostate Cancer Nuclear Medicine Diagnostics Market